Archive for the ‘Treatment’ Category

Somatic Tracking for Pain

**DISCLAIMER**

Sorry for the monologue, but it’s important.

As anyone in Lymeland knows, ‘what works for one, doesn’t work for another.’  Please keep this in mind as you read the following information that I hope will help someone.  Further, I am in complete disagreement with any statements that Lyme/MSIDS can not be a persistent/chronic infection(s).  The doctor in the documentary, Dr. Howard Schubiner, admits there is controversy in the medical community over chronic Lyme/MSIDS, and that he has had the experience of seeing patients ‘overtreated’ with antibiotics for weeks, months, and years. While he states he is very happy for those who are doing well with long-term of treatment, he states patients should rethink their diagnosis if they are on a merry-go-round of costly and invasive treatments that aren’t working. To this doctor I would state: while you have had the unfortunate experience of helping ‘overtreated’ patients, there are thousands upon thousands in the real world who are dying from undertreatment.  Tread lightly.

While rethinking a diagnosis appears to be logically sane thinking, it’s imperative to understand treating Lyme/MSIDS is fraught with confusion, mystery, set backs, and pain. To my knowledge the only other diseases with Jarisch-Herxheimer reactions besides Lyme disease are syphilis, leptospirosis, and relapsing fever – which means unless you have had one of those diseases before, you have never experienced how confusing and relentless herxes are. They truly make you think you are losing your mind.

It is not uncommon at all for patients to hit plateaus in Lyme/MSIDS treatment. They might go through a period where they feel great only to have the dreaded symptoms, or even worse ones appear over night.  This is why Lyme literate doctors describe treating this similarly to peeling back the layers of an onion.  When one infection gets under control another one suddenly becomes visible.

This coinfection involvement never gets any air-play, but is crucial in understanding this beast. These infections require different medications entirely, but mainstream medicine doesn’t even consider them, so when a short course of doxy doesn’t make a person well, they simply fold up shop and declare, “you don’t have Lyme,” which could very well be true; however, they could also have Babesia, Bartonella, Relapsing Fever, or a whole host of other infections that look and act just like Lyme disease. Please go here to learn of the many issues surrounding why patients don’t get well.

So, once again, none of this is simple.  Keep an open mind.

One final note: I ended up using many aspects of this technique out of desperation, completely on my own.  I had no idea it was a ‘thing,’ but as they say, ‘necessity is the mother of invention.’

https://careclinic.io/somatic-tracking-pain/

Somatic Tracking for Pain: Unveiling Effective Techniques

somatic tracking pain

Living with pain can be a daunting and overwhelming experience. It can drastically affect our quality of life and prevent us from fully enjoying the activities we love. However, there is a technique called somatic tracking that can help us better understand and manage our pain. In this article, we will delve into the intricacies of somatic tracking, explore its benefits, and discuss how it can be implemented in our daily lives.

Understanding Somatic Tracking

Somatic tracking is a mindfulness-based technique that involves bringing awareness to our bodily sensations and learning to interpret them. By paying attention to our physical experiences, we can develop a deeper understanding of the underlying causes of our pain and explore ways to alleviate it.

When we talk about somatic tracking, we are referring to the practice of tuning in to the sensations and signals that our bodies send us. It’s like becoming fluent in the language of our own physical experiences. Just as we can learn to interpret words and phrases in a foreign language, we can learn to interpret the messages that our bodies are constantly sending us.

Imagine this: you wake up one morning with a dull ache in your lower back. Instead of dismissing it as just another discomfort, you decide to practice somatic tracking. You close your eyes, take a deep breath, and bring your attention to the area of your back that is bothering you. As you focus on the sensation, you start to notice subtle nuances – a tightness, a twinge, a warmth. These sensations become the building blocks of your understanding.  (See link for article)

________________

https://www.curablehealth.com/podcast/what-is-somatic-tracking  Podcast Here

A Podcast Where Real Chronic Pain Sufferers Meet Science-Backed Solutions 💫

Join us as our expert hosts help listeners overcome obstacles to healing through evidence-based techniques.

Go here for a Somatic Tracking exercise, and here for 10 best exercises

And here for an excerpt from The Way Out: A Revolutionary, Scientifically Proven Approach to Healing Chronic Pain by Alan Gordon and Alon Ziv, the speakers from the podcast above.

And here for one person’s successful experience with Somatic Tracking without using drugs or getting surgery.

It is described as physical therapy for the brain.

https://www.thismighthurtfilm.com/

This Might Hurt

A Film about a radical treatment for chronic pain

THE PROBLEM: CHRONIC PAIN

One in seven people around the world suffer from chronic pain, and nearly 80% of us will experience it at some point in our lives. The symptoms show up as back pain, neck pain, fibromyalgia, migraines, irritable bowel syndrome, anxiety, depression, fatigue, and a dozen others. The standard treatments are often ineffective, and one of the main remedies, opioids, has made the problem worse. What’s going on here?

THE FILM

This Might Hurt is a documentary that offers solutions to reduce and unlearn chronic pain. The film follows three chronic pain patients who have spent years searching for answers. Desperate for relief, they enter a new medical program — run by Dr. Howard Schubiner — that focuses on uncovering hidden causes of pain, and retraining their brains to switch the pain off.

This new paradigm for diagnosis and treatment was found to be effective in several randomized trials, and was listed as a “best practice” by the HHS’s task force to combat the opioid epidemic. This Might Hurt provides an intimate exploration and suggests a path to healing for millions.

Here are just some of the conditions that can be caused by “primary pain,” also know as brain-generated pain:

Brain Induced Conditions.gif

*These treatments are generally not recommended for people dealing with “secondary pain,” that is, pain that derives from cancer, fractures, muscle diseases, or infections.

NOT SURE IF THESE IDEAS APPLY TO YOUR SYMPTOMS?

HowardLecture3.jpg

5 STEPS TO UNLEARNING CHRONIC PRIMARY PAIN EXPLORED IN THIS MIGHT HURT

//cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FLCGF0SXk50M%3Ffeature%3Doembed&display_name=YouTube&url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DLCGF0SXk50M&image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FLCGF0SXk50M%2Fhqdefault.jpg&key=c6502efcb3c84824bc6c1f27d683be13&type=text%2Fhtml&schema=youtube”,”url”:”https://www.youtube.com/watch?v=LCGF0SXk50M”,”width”:854,”height”:480,”resolvedBy”:”youtube”,”providerName”:”YouTube”,”thumbnailUrl”:”https://i.ytimg.com/vi/LCGF0SXk50M/hqdefault.jpg”}” data-block-type=”22″>

There are published studies demonstrating the effectiveness of mind-body treatment for people who have a similar collection of symptoms, but who were labeled as having fibromyalgia, not chronic Lyme. But there has not been a study of the mind-body treatment for people labeled as chronic Lyme disease, to our knowledge.

Category:

Lyme, Pain Management, Treatment

Meningitis Secondary to Lyme Disease: Case Report

https://danielcameronmd.com/case-report-meningitis-secondary-to-lyme-disease/

CASE REPORT: MENINGITIS SECONDARY TO LYME DISEASE

lyme-disease-meningitis

In this case report, “Meningitis in the Guise of Dementia: Lyme-Induced Normal Pressure Hydrocephalus,” Liu and colleagues review the case of an elderly patient with dementia, found to have Lyme meningitis in the setting of a normal pressure hydrocephalus (NPH). [1]

By 

An 80-year-old man was admitted to a hospital in Pennsylvania, an area endemic for Lyme disease, due to increased weakness and confusion. He had “several days of nausea with decreased appetite, generalized malaise, fatigue, and weakness,” according to the authors.

Cerebrospinal fluid (CSF) studies suggested aseptic meningitis. And a CT scan showed dilated ventricles. Treatment for normal pressure hydrocephalus relieved his symptoms.

On the fourth day of hospitalization, the man tested positive for Lyme disease by Western blot on bands 23KD and 39KD.

“Healthcare providers treating patients with NPH should consider Lyme disease as a differential diagnosis because of the multiple reported cases of NPH secondary to Lyme disease.”

“The patient was subsequently diagnosed with aseptic meningitis secondary to Lyme,” the authors state.

He was treated with IV and oral doxycycline. But his dementia did not completely resolve, “likely due to primary dementia or other condition.”

“In the case of our patient, infectious meningitis was suspected due to this patient reportedly having had fevers and leukocytosis. Additionally, Lyme disease is among the most common reportable infections in Pennsylvania,” the authors state.

Authors Conclude:

“Lyme disease … can present with multiple complications, including arthritis, heart rhythm defects, facial nerve palsy, impaired memory, and meningitis. Hence, Lyme disease should be considered as part of the differential etiology of meningitis.

Related Articles:

Lyme disease presents as brachial plexopathy and meningitis
One year after infection, patient shows signs of Lyme meningitis
Lyme meningitis leading to hyponatremia

References:
  1. Liu R, Polly M, Lennon RP, Reedy-Cooper A. Meningitis in the Guise of Dementia: Lyme-Induced Normal Pressure Hydrocephalus. Clin Med Res. 2023 Dec;21(4):226-229. doi: 10.3121/cmr.2023.1829. PMID: 38296639.

_______________

**Comment**

Again, doxy is a great front-line drug but hardly a panacea.

Coinfections are never considered or talked about.

For more:

Category:

Lyme, research, Testing, Treatment

Chlorine Dioxide & Natural Medicine: Kerri Rivera

https://robertyoho.substack.com/p/298-kerri-rivera-returns-to-reveal?  Audio Here

KERRI RIVERA RETURNS TO REVEAL MORE SECRETS OF NATURAL MEDICINE

Kerri Rivera kindly returned for a second interview about chlorine dioxide and other natural medicines. She began studying natural health to save her vaccine-injured son from autism years before Kalcker or Humble appeared on the scene. This makes Kerri an OG, an Original Gangster. This phrase is a rapper complement that now means a respected or old-school source.

Kerri deserves to be heard because of her depth of experience and training with some of the best healers in the world. If you haven’t, listen to her first interview HERE. She helped me clear up some of my confusion about alternative medicine. Kerri is a homeopath who offers online consultations. Email her at kerri@kerririvera.com if you are interested.  (See link for article and interview)  Go here for the Rumble video version

______________

Important quote:

“Chlorine dioxide (CD) is foundational; methylene blue is adjunctive.”

A BIG THANKS to Dr. Yoho for summarizing the video in the link above.  Most people don’t do this and it frustrates me to no end as most of us don’t have time to listen to hour plus interviews!

He also lists dosages and frequency as well as other helpful tidbits.

Notice that desperation for her son’s health is what drove Rivera to find this treatment.  I have seen this play out over and over again.  People who are vested in finding real answers find things people who just get a paycheck don’t.

Please also see:

Category:

Activism, Detoxing, diet and nutrition, Supplements, Treatment, Viruses

Senate Panel on ‘Vaccines’- The Red Pill We’ve All Been Waiting for

https://www.midwesterndoctor.com/p/this-senate-panel-on-the-vaccines

This Senate Panel On The Vaccines Is The Red Pill We’ve All Been Waiting For

This excellent presentation meticulously breaks down exactly what went awry throughout COVID-19. What everyone needs to know is summarized below.

A MIDWESTERN DOCTOR
FEB 29, 2024

Article Excerpt:

A lot of work has gone into producing each of the vaccine panels he’s hosted. On Monday, he hosted “Federal Health Agencies and the COVID Cartel: What Are They Hiding?” When it was all said and done, I believe this panel was the most effective presentation I have seen for explaining what happened throughout COVID-19 and waking people up to how much they have been lied to. Because of this I strongly encourage you to watch or share his presentation with people who you think might be open to understanding exactly what was done to all of us. This article will begin with his entire panel:

Lastly, for those who prefer to read, a transcript of Johnson’s symposium can be found here.  (See link for article and videos)

_______________

**Comment**

Admittedly, the article is long; however, there’s a lot of history to record.

The author took a lot of time to highlight important parts. Video highlights include:

  • Edward Dowd’s work on excess deaths
  • Kevin McKernan’s discovery of DNA plasmid contamination and its connection with cancer
  • Dr. Harvey Risch’s overview of the bioweapons industry
  • Barbara Loe Fisher’s work with vaccine advocacy
  • Brian Hooker’s 23 years of work (15 peer-reviewed papers) on vaccine injuries
  • Del Bigtree’s decade of vaccine advocacy work
  • Dr. Sabine Hazan’s work on existing therapies to treat COVID
  • Dr. Pierre Kory’s work on repurposed drugs for COVID
  • Dr. Christian Perron’s work showing how HCQ and azithromycin lowered COVID death rate got him fired from his 26 year professorship.
  • Raphael Lataster, a leading researcher exposing fraud within COVID vaccine trials
  • Journalist Lara Logan exposed how journalism has been hijacked by the government
  • Matthias Desmet gave a summary of crowd psychology
  • Brett Weinstein talked about malicious forces taking away truth and justice

And many, many more.

Note: for anyone considering being a whistleblower, Johnson requested for you to contact his office here.

The article above is written by A Midwestern Doctor, an experienced doctor who wishes to remain anonymous for obvious reasons. I highly recommend subscribing to this particular Substack as it is very informative and one of the few places you will hear details mainstream media and ‘science’ omit such as:

Category:

Activism, Cancer, research, Treatment, vaccines, Viruses

Novel Lyme Antibiotic Heads For Human Safety Trials

https://news.northeastern.edu/2024/02/28/lyme-antibiotic-treatment-human-trials/

Experimental antibiotic treatment for Lyme heads for human safety trials

By Cynthia McCormick Hibbert, Northeastern University

2/28/24

Human safety trials of a novel antibiotic treatment for Lyme disease developed by Northeastern professor Kim Lewis are scheduled to start this spring in Australia, with results anticipated by fall.

“Hopefully, the results will be positive,” says Lewis, University Distinguished Professor of Biology.

So far the therapeutic agent, an antibiotic known as hygromycin A, has not been toxic in animals and has cleared Lyme in mice, he says.

Existing standard treatments for Lyme disease, doxycycline and amoxicillin, have proved far from silver bullets for the nearly half-million people stricken by the tick-borne illness in the U.S. each year.

The Centers for Disease Control and Prevention estimates that 5% to 10% of Lyme patients have persistent symptoms after early treatment, while the Global Lyme Alliance says that as many as 2 million Americans could suffer post-treatment disability.

Overlooked antibiotic

Lewis says that hygromycin A is different from the broad spectrum antibiotics in that it specifically targets spirochetes including Borrelia burgdorferi, the spiral-shaped bacterium that transmits Lyme disease through the bite of a deer tick.

The expectation is not only that hygromycin A will prove more effective in curing Lyme disease in the early, acute stage but that it could also mop up residual pathogens that may persist in some patients with chronic disease, Lewis says.

He suspects many cases of chronic Lyme symptoms are caused by changes to patients’ microbiomes due to the use of broad spectrum antibiotics.

With hygromycin’s specific targeting of spirochetes, Lewis says that is less likely to lead to chronic disease.

“What we’re testing for now is a treatment for acute Lyme that will be more effective and won’t wreck the microbiome and will hopefully lead to fewer chronic cases,” he says.

People with chronic, long-term or persistent Lyme call it a life-changing experience, leaving them with arthritis, cardiac problems, fatigue, brain fog, depression and anxiety.

Made by a bacterium found in the soil, hygromycin A has been a known but overlooked antimicrobial since 1953, Lewis says.

“Nobody really cared about this compound because it’s very weak against regular bacteria. What we discovered is that it is indeed very weak against regular pathogens but exceptionally potent against spirochetes.”

Phase 1 trials set for April

Lewis’ team has licensed the compound to Flightpath, a biotech company focused on Lyme disease that is conducting the phase 1 trial scheduled to start in April. Flightpath is leading the clinical development effort with funding from the Cohen Foundation.

“A safety trial simply asks the question, ‘Is it safe for healthy people to take this drug,’” Lewis says.

If it passes toxicity screenings, it can advance to phase 2 to determine effective dosing ranges “and see if it cures acute Lyme disease,” he says.

Success at that stage would lead to a clinical trial involving a larger group of patients, with the possible end result of requesting FDA approval for the treatment via a new drug application.

Even if approved, human efficacy trials probably wouldn’t start until 2025, Lewis says.

That hasn’t stopped the Global Lyme Alliance, which helped fund Lewis’ Lyme drug discovery program, from expressing excitement over the prospect of seeing hygromycin A in doctors’ hands.

In a statement on Instagram in February, the alliance quoted Flightpath CEO Matt Tindall saying that reaching this stage is a “landmark achievement for Lyme patients.”

If the trials make it to phase 2, researchers will reach out to Lyme specialists at places such as Johns Hopkins and Massachusetts General Hospital to recruit Lyme patients for the study, Lewis says.

Most projects that researchers in academia and industry toil on for years “do not get to the point when we feel, based on extensive animal studies, that the compound has sufficient efficacy and safety features that we can now introduce it into humans,” Lewis says.

“We are at that point with hygromycin A. That is, of course, encouraging,” he says.

SOURCE: Northeastern University

______________

For more:

Category:

Activism, Lyme, research, Treatment